AIP
AKCA

Ameritas Investment Partners’s Akcea Therapeutics Inc AKCA Stock Holding History

Ameritas Investment Partners’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,275
Closed -$23K – 3139
2020
Q3 		$23K Hold
1,275
– – ﹤0.01% 2314
2020
Q2 		$17K Hold
1,275
– – ﹤0.01% 2453
2020
Q1 		$18K Hold
1,275
– – ﹤0.01% 2251
2019
Q4 		$22K Hold
1,275
– – ﹤0.01% 2380
2019
Q3 		$20K Hold
1,275
– – ﹤0.01% 2405
2019
Q2 		$30K Hold
1,275
– – ﹤0.01% 2215
2019
Q1 		$36K Hold
1,275
– – ﹤0.01% 2073
2018
Q4 		$38K Hold
1,275
– – ﹤0.01% 1972
2018
Q3 		$45K Hold
1,275
– – ﹤0.01% 2054
2018
Q2 		$30K Hold
1,275
– – ﹤0.01% 2287
2018
Q1 		$33K Hold
1,275
– – ﹤0.01% 2168
2017
Q4 		$22K Buy
+1,275
New +$25K ﹤0.01% 2395

Ameritas Investment Partners's AKCA Position: Q4 2020 in Review

Ameritas Investment Partners sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 1,275 shares — an estimated $23K sold.

Ameritas Investment Partners first reported a position in AKCA in Q4 2017 and held it in 12 quarters. The position peaked at $45K in Q3 2018. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Ameritas Investment Partners reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Ameritas Investment Partners sold 1,275 Akcea Therapeutics Inc shares in Q4 2020, an estimated $23K.
  • Ameritas Investment Partners first reported a position in Akcea Therapeutics Inc in Q4 2017 and held it in 12 quarters.
  • Ameritas Investment Partners's Akcea Therapeutics Inc position peaked at $45K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Ameritas Investment Partners's 13F filing for Q4 2020, filed 12 Feb 2021.